OTC Acne Treatment Labels Should Add Sensitivity Test Direction – FDA
This article was originally published in The Tan Sheet
Executive Summary
OTC topical acne drug product manufacturers have an option to add label directions for sensitivity testing for new users of their products, “to reduce the risk of serious hypersensitivity reactions,” the FDA says.
You may also be interested in...
FDA Evaluates Topical Acne Ingredients After Adverse Event Report Jump
A recent uptick in the number of adverse events reported for benzoyl peroxide and salicylic acid products has pushed the regulatory agency to take a closer look at the potential for safety issues.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.